Esbriet (pirfenidone) And The Risk Of Drug-induced Liver Injury
ESBRIET Recall Summary Health Canada is recalling ESBRIET (pirfenidone), a medication used to treat a type of lung disease called idiopathic pulmonary fibrosis, due to a risk of drug-induced liver injury. The recall affects ESBRIET products distributed across Canada. People taking this medication are potentially at risk.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-09-14
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/1c76d87e-3d62-4372-ab1d-0857eb575306